PortfoliosLab logoPortfoliosLab logo
IHE vs. XLV
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IHE vs. XLV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares U.S. Pharmaceuticals ETF (IHE) and State Street Health Care Select Sector SPDR ETF (XLV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IHE achieves a 5.25% return, which is significantly higher than XLV's -5.04% return. Over the past 10 years, IHE has underperformed XLV with an annualized return of 7.69%, while XLV has yielded a comparatively higher 9.12% annualized return.


IHE

1D
-1.44%
1M
1.13%
YTD
5.25%
6M
7.86%
1Y
38.69%
3Y*
17.02%
5Y*
9.73%
10Y*
7.69%

XLV

1D
-0.97%
1M
0.85%
YTD
-5.04%
6M
-4.36%
1Y
12.27%
3Y*
5.70%
5Y*
5.45%
10Y*
9.12%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IHE vs. XLV - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IHE
iShares U.S. Pharmaceuticals ETF
5.25%31.69%8.13%1.06%-4.87%13.07%13.66%15.47%-7.76%10.64%
XLV
State Street Health Care Select Sector SPDR ETF
-5.04%14.50%2.47%2.07%-2.08%26.04%13.30%20.45%6.28%21.77%

Correlation

The correlation between IHE and XLV is 0.85, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.85

Correlation (3Y)
Calculated over the trailing 3-year period

0.83

Correlation (5Y)
Calculated over the trailing 5-year period

0.84

Correlation (10Y)
Calculated over the trailing 10-year period

0.84

Correlation (All Time)
Calculated using the full available price history since May 8, 2006

0.86

The correlation between IHE and XLV has been stable across timeframes, ranging from 0.83 to 0.86 - a consistent structural relationship.

IHE vs. XLV - Sectors Allocation Comparison


Sectors
IHE
XLV

Healthcare

100.0%
100.0%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

IHE
100.0%
XLV
100.0%

Basic Materials

IHE

-

XLV

-

Communication Services

IHE

-

XLV

-

Consumer Cyclical

IHE

-

XLV

-

Consumer Defensive

IHE

-

XLV

-

Energy

IHE

-

XLV

-

Financial Services

IHE

-

XLV

-

Industrials

IHE

-

XLV

-

Real Estate

IHE

-

XLV

-

Technology

IHE

-

XLV

-

Utilities

IHE

-

XLV

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IHE vs. XLV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IHE
IHE Risk / Return Rank: 7272
Overall Rank
IHE Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
IHE Sortino Ratio Rank: 7373
Sortino Ratio Rank
IHE Omega Ratio Rank: 6464
Omega Ratio Rank
IHE Calmar Ratio Rank: 8585
Calmar Ratio Rank
IHE Martin Ratio Rank: 7373
Martin Ratio Rank

XLV
XLV Risk / Return Rank: 2424
Overall Rank
XLV Sharpe Ratio Rank: 2424
Sharpe Ratio Rank
XLV Sortino Ratio Rank: 2525
Sortino Ratio Rank
XLV Omega Ratio Rank: 2323
Omega Ratio Rank
XLV Calmar Ratio Rank: 2525
Calmar Ratio Rank
XLV Martin Ratio Rank: 2222
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IHE vs. XLV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Pharmaceuticals ETF (IHE) and State Street Health Care Select Sector SPDR ETF (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IHEXLVDifference

Sharpe ratio

Return per unit of total volatility

2.28

0.84

+1.44

Sortino ratio

Return per unit of downside risk

3.33

1.36

+1.97

Omega ratio

Gain probability vs. loss probability

1.39

1.15

+0.24

Calmar ratio

Return relative to maximum drawdown

4.65

1.18

+3.47

Martin ratio

Return relative to average drawdown

14.05

2.87

+11.18

IHE vs. XLV - Sharpe Ratio Comparison

The current IHE Sharpe Ratio is 2.28, which is higher than the XLV Sharpe Ratio of 0.84. The chart below compares the historical Sharpe Ratios of IHE and XLV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IHEXLVDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.28

0.84

+1.44

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.60

0.37

+0.23

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.43

0.55

-0.13

Sharpe Ratio (All Time)

Calculated using the full available price history

0.50

0.46

+0.05

Drawdowns

IHE vs. XLV - Drawdown Comparison

The maximum IHE drawdown since its inception was -38.20%, roughly equal to the maximum XLV drawdown of -39.17%. Use the drawdown chart below to compare losses from any high point for IHE and XLV.


Loading charts...

Drawdown Indicators


IHEXLVDifference

Max Drawdown

Largest peak-to-trough decline

-38.20%

-39.17%

+0.97%

Max Drawdown (1Y)

Largest decline over 1 year

-8.47%

-10.47%

+2.00%

Max Drawdown (3Y)

Largest decline over 3 years

-15.92%

-17.11%

+1.19%

Max Drawdown (5Y)

Largest decline over 5 years

-16.03%

-17.11%

+1.08%

Max Drawdown (10Y)

Largest decline over 10 years

-29.59%

-28.40%

-1.19%

Current Drawdown

Current decline from peak

-3.91%

-8.24%

+4.33%

Average Drawdown

Average peak-to-trough decline

-7.92%

-7.12%

-0.80%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.80%

4.30%

-1.50%

Volatility

IHE vs. XLV - Volatility Comparison

iShares U.S. Pharmaceuticals ETF (IHE) has a higher volatility of 5.43% compared to State Street Health Care Select Sector SPDR ETF (XLV) at 4.05%. This indicates that IHE's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IHEXLVDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.43%

4.05%

+1.38%

Volatility (6M)

Calculated over the trailing 6-month period

12.51%

10.32%

+2.19%

Volatility (1Y)

Calculated over the trailing 1-year period

17.05%

14.65%

+2.40%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.23%

14.69%

+1.54%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.05%

16.55%

+1.50%

IHE vs. XLV - Expense Ratio Comparison

IHE has a 0.42% expense ratio, which is higher than XLV's 0.08% expense ratio.


Dividends

IHE vs. XLV - Dividend Comparison

IHE's dividend yield for the trailing twelve months is around 1.67%, less than XLV's 1.71% yield.


PositionTTM20252024202320222021202020192018201720162015
IHE
iShares U.S. Pharmaceuticals ETF
1.67%1.76%1.73%1.39%2.01%1.49%1.19%1.40%1.25%1.36%0.92%1.93%
XLV
State Street Health Care Select Sector SPDR ETF
1.71%1.60%1.67%1.59%1.47%1.33%1.49%2.17%1.57%1.47%1.60%1.43%

Frequently Asked Questions


IHE and XLV have a correlation of 0.85, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IHE has higher volatility (5.43%) compared to XLV (4.05%). In terms of maximum drawdown, IHE dropped -38.20% vs XLV's -39.17%.

On 10-year performance, XLV leads with 9.12% vs 7.69% for IHE. On fees, XLV is cheaper at 0.08% per year. On volatility, XLV has been the lower-risk option at 4.05%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, XLV has performed better with a 9.12% return vs 7.69%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

XLV is cheaper with a 0.08% expense ratio, compared with 0.42% for IHE.

XLV has the higher dividend yield at 1.71%, compared with 1.67% for IHE.

IHE tracks Dow Jones U.S. Select Pharmaceuticals Index, while XLV tracks Health Care Select Sector Index. They also come from different issuers: iShares and State Street. Their fees differ too: 0.42% for IHE and 0.08% for XLV.

IHE currently has the higher Sharpe Ratio (2.28 vs 0.84), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IHE and XLV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer